​

Metabolomycs, Inc. is a Southern California-based biotechnology company that has pioneered the clinical application of next-generation metabolomics for the study of human disease. Applying Mass Spectrometry, Metabolomyc’s platform utilizes biochemical signatures to identify inborn-like errors of metabolism that underlie many human illnesses, offering the opportunity for earlier diagnosis and improved treatment. Metabolomyc’s analyses unlock the secrets of your metabolism.